Oral Minoxidil: Blood Pressure Uses, Hair-Loss Context and Safety

Oral tablets and approved use

This page covers systemic minoxidil taken by mouth. The reviewed UK Loniten 5 mg tablet label concerns severe hypertension. It must not be treated as interchangeable with a scalp solution, foam or a differently formulated tablet; the generic medicine record includes imported oral products with other strengths.

For hypertension, the UK label requires accompanying treatment to control fluid retention and the reflex rise in heart rate. The combination and monitoring plan belong to the treating clinician. Starting, changing or stopping these medicines independently can undermine that plan.

Does oral minoxidil have approval for hair loss?

The reviewed US oral-tablet label explicitly says that promoting hair growth is not an approved indication. Hair-loss prescribing of oral minoxidil is therefore an off-label context under that label. Approval and experience with a topical scalp preparation do not automatically validate a tablet dose or a homemade topical preparation made from tablets.

An online description of a low dose does not replace evaluation of cardiovascular history or other medicines. The product name, route and reason for prescribing should all be clear before different forms are compared.

Side effects and serious warning signs

The UK label identifies increased body hair, a faster heartbeat and fluid retention as relevant adverse effects. Blood pressure, weight and fluid balance require follow-up. It advises against use in pregnancy and requires an individual breastfeeding decision because minoxidil passes into milk.

The US boxed warning highlights fluid around the heart, sometimes progressing to tamponade, and worsening angina. New chest pain, breathlessness, marked swelling, faintness or rapid weight gain needs prompt medical assessment. Kidney impairment can make supervision especially important; a cosmetic reason for prescribing does not remove systemic risks.

Interactions to discuss

Other medicines with blood-pressure-lowering effects may add to the effect of minoxidil. The labels particularly warn that guanethidine can produce profound postural blood-pressure falls when combined with it. Keep an up-to-date list of prescribed medicines and tell the treating team about dizziness or near-fainting when standing. This summary does not provide a personal dose, companion-drug choice or switching schedule.

Sources and scope

• Loniten 5 mg oral tablets: UK SmPC — Pfizer; text revised February 2026
• Minoxidil oral tablets: US prescribing information — A-S Medication Solutions repackaged label; DailyMed updated 10 November 2025

Sources checked: 30 October 2026. This records a source check, not a clinical review by a doctor or pharmacist. The current leaflet for the actual product and professional assessment guide personal treatment.